Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1175652.RApWuPPVtDR0lqPU_bu9yKn7tab73iE3OUm_nOzKlPRVg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1175652.RApWuPPVtDR0lqPU_bu9yKn7tab73iE3OUm_nOzKlPRVg130_assertion type Assertion NP1175652.RApWuPPVtDR0lqPU_bu9yKn7tab73iE3OUm_nOzKlPRVg130_head.
- NP1175652.RApWuPPVtDR0lqPU_bu9yKn7tab73iE3OUm_nOzKlPRVg130_assertion description "[We assessed by immunohistochemistry the expression of EGFR, KIT, MET, PDGFRB, VEGF, VEGFR1, VEGFR2, and VEGFR3 in a series of 84 primary MTC tumors that had previously been molecularly characterized, including 14 RAS-positive, 18 RET(M918T)-positive, and 24 RET(C634)-positive tumors, as well as 15 wild-type tumors with no mutations in the RET or RAS genes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1175652.RApWuPPVtDR0lqPU_bu9yKn7tab73iE3OUm_nOzKlPRVg130_provenance.
- NP1175652.RApWuPPVtDR0lqPU_bu9yKn7tab73iE3OUm_nOzKlPRVg130_assertion evidence source_evidence_literature NP1175652.RApWuPPVtDR0lqPU_bu9yKn7tab73iE3OUm_nOzKlPRVg130_provenance.
- NP1175652.RApWuPPVtDR0lqPU_bu9yKn7tab73iE3OUm_nOzKlPRVg130_assertion SIO_000772 24754736 NP1175652.RApWuPPVtDR0lqPU_bu9yKn7tab73iE3OUm_nOzKlPRVg130_provenance.
- NP1175652.RApWuPPVtDR0lqPU_bu9yKn7tab73iE3OUm_nOzKlPRVg130_assertion wasDerivedFrom befree-2016 NP1175652.RApWuPPVtDR0lqPU_bu9yKn7tab73iE3OUm_nOzKlPRVg130_provenance.
- NP1175652.RApWuPPVtDR0lqPU_bu9yKn7tab73iE3OUm_nOzKlPRVg130_assertion wasGeneratedBy ECO_0000203 NP1175652.RApWuPPVtDR0lqPU_bu9yKn7tab73iE3OUm_nOzKlPRVg130_provenance.